DE69125262D1 - Synergische Mischung zur Behandlung von Herpes - Google Patents

Synergische Mischung zur Behandlung von Herpes

Info

Publication number
DE69125262D1
DE69125262D1 DE69125262T DE69125262T DE69125262D1 DE 69125262 D1 DE69125262 D1 DE 69125262D1 DE 69125262 T DE69125262 T DE 69125262T DE 69125262 T DE69125262 T DE 69125262T DE 69125262 D1 DE69125262 D1 DE 69125262D1
Authority
DE
Germany
Prior art keywords
herpes
treatment
synergic mixture
combination
synergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69125262T
Other languages
English (en)
Other versions
DE69125262T2 (de
Inventor
Robert Deziel
Yvan Guindon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Bio Mega Boehringer Ingelheim Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim Research Inc filed Critical Bio Mega Boehringer Ingelheim Research Inc
Application granted granted Critical
Publication of DE69125262D1 publication Critical patent/DE69125262D1/de
Publication of DE69125262T2 publication Critical patent/DE69125262T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69125262T 1990-12-31 1991-12-21 Synergische Mischung zur Behandlung von Herpes Expired - Fee Related DE69125262T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002033447A CA2033447C (en) 1990-12-31 1990-12-31 Synergistic combination for treating herpes infections

Publications (2)

Publication Number Publication Date
DE69125262D1 true DE69125262D1 (de) 1997-04-24
DE69125262T2 DE69125262T2 (de) 1997-10-09

Family

ID=4146736

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125262T Expired - Fee Related DE69125262T2 (de) 1990-12-31 1991-12-21 Synergische Mischung zur Behandlung von Herpes

Country Status (9)

Country Link
US (1) US5380727A (de)
EP (1) EP0493767B1 (de)
JP (1) JP3209553B2 (de)
AT (1) ATE150317T1 (de)
AU (1) AU648854B2 (de)
CA (1) CA2033447C (de)
DE (1) DE69125262T2 (de)
IL (1) IL100550A (de)
NZ (1) NZ241120A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69320390T2 (de) * 1992-03-12 1999-02-11 Boehringer Ingelheim (Canada) Ltd., Laval, Quebec Isosterische Peptidderivate gegen Herpes
JP4110347B2 (ja) * 1999-11-05 2008-07-02 大鵬薬品工業株式会社 抗ｈｉｖ剤
DE60130641T2 (de) * 2000-02-07 2008-06-26 Wisconsin Alumni Research Foundation, Madison Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung
WO2005060541A2 (en) * 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection
US9376438B2 (en) 2011-05-17 2016-06-28 Principia Biopharma, Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
JP5974084B2 (ja) 2011-05-17 2016-08-23 プリンシピア バイオファーマ インコーポレイテッド チロシンキナーゼ阻害剤
NZ630925A (en) 2012-09-10 2016-10-28 Principia Biopharma Inc Pyrazolopyrimidine compounds as kinase inhibitors
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
ES2841248T3 (es) 2014-02-21 2021-07-07 Principia Biopharma Inc Sales y forma sólida de un inhibidor de BTK
US10485797B2 (en) 2014-12-18 2019-11-26 Principia Biopharma Inc. Treatment of pemphigus
US20180305350A1 (en) 2015-06-24 2018-10-25 Principia Biopharma Inc. Tyrosine kinase inhibitors
CN115054586B (zh) 2016-06-29 2024-08-02 普林斯匹亚生物制药公司 改性的释放制剂
JP6510578B2 (ja) 2017-03-28 2019-05-08 本田技研工業株式会社 ヘッドアップディスプレイ装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor

Also Published As

Publication number Publication date
ATE150317T1 (de) 1997-04-15
CA2033447C (en) 1999-08-31
AU648854B2 (en) 1994-05-05
DE69125262T2 (de) 1997-10-09
EP0493767A3 (en) 1993-03-17
US5380727A (en) 1995-01-10
AU9009191A (en) 1992-07-02
NZ241120A (en) 1994-02-25
JPH04275230A (ja) 1992-09-30
IL100550A0 (en) 1992-09-06
EP0493767B1 (de) 1997-03-19
JP3209553B2 (ja) 2001-09-17
IL100550A (en) 1995-11-27
EP0493767A2 (de) 1992-07-08
CA2033447A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
ATE150317T1 (de) Synergische mischung zur behandlung von herpes
KR950702564A (ko) 비스-스타우로스포린 및 케이-252에이(K-25a)유도체(BIS-STAUROSPORINE AND K-252a DERIVATIVES)
DE69318433D1 (de) Verfahren zur Behandlung von Verbrennungsabgasen
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
NZ241121A (en) Antiviral composition for treating herpes comprising a nucleoside analog & a ribonucleotide reductase inhibiting peptide derivative
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
NO924815D0 (no) Fremgangsmaate for overflatebehandling av en gjenstand
ATE281169T1 (de) Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen
DE69125610D1 (de) Penciclovir und famciclovir und verwandte guaninderivate zur behandlung von hiv-1-infektionen
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE69635131D1 (de) Verwendung von beta-interferon zur behandlung der restenose
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
ZA913651B (en) Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates
MX9301694A (es) Peptidos antivirales

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BOEHRINGER INGELHEIM (CANADA) LTD., LAVAL, QUEBEC,

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee